Beam Therapeutics, Inc. (BEAM)
31.39
+1.06
(+3.49%)
USD |
NASDAQ |
Apr 17, 16:00
30.89
-0.50
(-1.59%)
After-Hours: 06:55
Beam Therapeutics SG&A Expense (Quarterly) : 32.28M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Twist Bioscience Corp. | 69.74M |
| Intellia Therapeutics, Inc. | 33.08M |
| Stryker Corp. | 2.227B |
| Zimmer Biomet Holdings, Inc. | 872.30M |
| Tandem Diabetes Care, Inc. | 113.10M |